Synaglin-MV1 Tablet is an anti-diabetic medicine used to treat type 2 diabetes mellitus. Type 2 diabetes is a chronic or lifelong condition that affects the way your body processes glucose. People with type 2 diabetes either do not produce enough insulin or, if any insulin is produced, it is unable to perform its function in the body (insulin resistance).
Synaglin-MV1 Tablet is a combination of Glimepiride, Metformin and Voglibose which help control blood sugar levels. This medicine works by increasing the amount of insulin released by the pancreas. You must continue following the diet and exercise recommended for you whilst on treatment with Synaglin-MV1 Tablet .
Not everyone who is taking Synaglin-MV1 Tablet will get these side effects. The most common side effect of Synaglin-MV1 Tablet is hypoglycemia (low blood glucose levels), characterised by dizziness, sweating, hunger pangs, dry mouth and skin, etc. Other side effects include changes in taste, nausea, diarrhoea, stomach pain, headache, and upper respiratory symptoms.
Synaglin-MV1 Tablet should be taken with food to avoid an upset stomach. For optimal results, it is recommended to take it at the same time each day. For better advice, your doctor will determine the appropriate dose, which can change quickly depending on your condition. Do not skip your meals, and also carry a form of sugar with you to prevent low blood sugar levels.
Avoid taking Synaglin-MV1 Tablet if you are allergic to it. Synaglin-MV1 Tablet should not be stopped even if you feel better without consulting your doctor, as sugar levels may change. If you stop taking Synaglin-MV1 Tablet abruptly, it may increase your sugar levels, which could further increase the risk of eyesight loss (retinopathy), kidney damage (nephropathy) and nerve damage (neuropathy). Synaglin-MV1 Tablet should not be taken if you have type 1 diabetes mellitus or severe kidney or liver disease. Please inform your doctor if you have any heart disease or are planning to get pregnant or breastfeed.
Synaglin-MV1 Tablet is used in the treatment of Type 2 diabetes mellitus. The detailed uses of Synaglin-MV1 Tablet are as follows:
- Management of Type 2 Diabetes: Synaglin-MV1 Tablet effectively controls blood sugar levels in adults with type 2 diabetes, regulating glucose metabolism and maintaining optimal sugar levels.
- Enhanced Insulin Sensitivity: Synaglin-MV1 Tablet improves the body’s insulin response, facilitating glucose uptake and reducing insulin resistance.
- Prevention of Diabetes-Related Complications: Synaglin-MV1 Tablet helps to prevent long-term complications associated with diabetes, such as kidney damage, nerve damage, and vision problems.
Directions for Use
- Synaglin-MV1 Tablet should be taken before meals or as advised by your doctor.
- Follow your doctor’s instructions on the dosage and timing of this medication.
- Swallow Synaglin-MV1 Tablet as a whole with a glass of water.
- Do not crush, break, or chew it.
Medicinal Benefits
- Synaglin-MV1 Tablet contains Glimepiride, Metformin and Voglibose used to treat type 2 diabetes mellitus.
- Metformin acts by lowering the glucose production in the liver, delaying glucose absorption from the intestines and increasing the body’s response to insulin.
- Voglibose prevents the breakdown of complex sugars into simple sugars such as glucose in the intestine.
- Synaglin-MV1 Tablet prevents the blood glucose levels from rising to very high levels, thus keeping your diabetes under control.
- Synaglin-MV1 Tablet also helps to prevent serious complications of diabetes such as kidney damage (diabetic nephropathy), blindness (diabetic retinopathy), and loss of sensation in your hands and feet (diabetic neuropathy).
- Synaglin-MV1 Tablet also helps to reduce your chance of having a heart attack or stroke.
- Being a combination of three drugs, Synaglin-MV1 Tablet reduces the need to take multiple pills and hence makes it easier to remember to take the drugs.
How Synaglin-MV1 Tablet Works
Synaglin-MV1 Tablet is a combination of three antidiabetic drugs: Glimepiride, Metformin and Voglibose. Glimepiride, which is a ‘sulfonylurea’, acts by increasing the amount of insulin released by the pancreas. Together, these prevent the blood glucose levels from rising to very high levels, thus keeping your diabetes under control.
Storage
• Store in a cool and dry place away from sunlight. • Keep out of sight and reach of children. • Non cold chain – To be stored in cool places at 10ºC to 25ºC or below 30ºC.
What if I have taken an overdose of Synaglin-MV1 Tablet
Do not take more than the prescribed dose of Synaglin-MV1 Tablet as it may cause overdose resulting in mild hypoglycemia (low blood sugar). If you suspect you have taken overdose or have symptoms of overdose, please consult a doctor immediately.
Drug Warnings
- Inform your doctor if you are allergic to Synaglin-MV1 Tablet .
- This medicine should not be used in patients with type 1 diabetes or with diabetic ketoacidosis. Some diabetic patients, while taking Synaglin-MV1 Tablet , might develop a rare but serious condition called lactic acidosis (too much lactic acid accumulated in the blood) that can damage the working of your liver and kidneys, which are required for the elimination of excess lactic acid from the blood.
- Before you start taking Synaglin-MV1 Tablet , tell your doctor if you’ve ever had pancreatitis (inflammation of the pancreas), kidney disease, or a low vitamin B12 level.
- Synaglin-MV1 Tablet , when used with insulin, may extremely lower the blood sugar level, leading to a hypoglycemic condition, which can be fatal.
- Prolonged intake of Synaglin-MV1 Tablet may lower your thyroid-stimulating hormone (TSH); hence, an annual check-up of TSH is recommended.
- In rare cases, you may also develop a serious skin reaction known as bullous pemphigoid that requires immediate medical attention.
- It is always important to check for the expiry of the medicine. Discard the medicine if it reaches the expiry date.
